Stephen V. Liu, MD

Stephen V. Liu, MD, is a thoracic medical oncologist and an Associate Professor of Medicine at Georgetown University. He is the Director of Thoracic Oncology and the Head of Developmental Therapeutics at the Georgetown University Lombardi Comprehensive Cancer Center. He is also co-host of the official IASLC podcast, Lung Cancer Considered.

Articles by Stephen V. Liu, MD

Stephen V. Liu, MDConference Coverage | August 15, 2025
Dr. Liu shares why the meeting is a key chance for connections, collaborations, and conversations about the latest data.
View More
Millie Das, MDExpert Interviews | July 29, 2025
In the final segment of the roundtable discussion, the panel reflects on pressing unanswered questions in lung cancer.
Millie Das, MDExpert Interviews | July 29, 2025
In the fourth segment of this roundtable discussion, the panel weighs in on the most pressing unmet needs in NSCLC.
Millie Das, MDExpert Interviews | July 29, 2025
In the third segment of this roundtable discussion, the panel discusses considerations for community oncologists.
Millie Das, MDExpert Interviews | July 29, 2025
In the second segment of this roundtable discussion, the panel discusses the molecular testing landscape in NSCLC.
Millie Das, MDExpert Interviews | July 29, 2025
In the first segment of this roundtable discussion, the panel explores the rising incidence of young-onset lung cancer.
Stephen V. Liu, MDEGFR+ NSCLC | July 17, 2025
Dr. Liu discusses the implications of the accelerated approval and what the future may hold.
Stephen V. Liu, MDSmall Cell Lung Cancer | July 11, 2025
Dr. Liu explains how these two studies are shaping standards of care and the treatment landscape in SCLC.
Sanjay Juneja, MDLung Cancer | June 27, 2025
The forum covered critical updates in the fields of NSCLC, SCLC, immunotherapy effectiveness, and recent trial updates.
Sanjay Juneja, MDSmall Cell Lung Cancer | June 27, 2025
The panel discussed advancements in the field, including results from a study of lurbinectedin plus atezolizumab for SCLC.
Sanjay Juneja, MDNon-Small Cell Lung Cancer | June 25, 2025
Sanjay Juneja, MD, with experts Dr. Liu, Dr. Das, and Dr. Singhi, answered major questions about oncology referrals in NSCLC.
Sanjay Juneja, MDNon-Small Cell Lung Cancer | June 25, 2025
Sanjay Juneja, MD, with experts Dr. Liu, Dr. Das, and Dr. Singhi, answered major questions about recent NSCLC innovations.
Sanjay Juneja, MDNon-Small Cell Lung Cancer | June 25, 2025
Sanjay Juneja, MD, directed a discussion with Dr. Liu, Dr. Das, and Dr. Singhi on key updates in the field of NSCLC.
Stephen V. Liu, MDASCO 2025 | June 24, 2025
Dr. Liu weighs in on the CheckMate 816 data presented at the 2025 ASCO Annual Meeting.
Stephen V. Liu, MDNon-Small Cell Lung Cancer | June 24, 2025
Stephen Liu, MD, shares his insights on the recent approval, the data behind it, and what the future may hold.
Stephen V. Liu, MDConference Coverage | June 1, 2025
Stephen V. Liu, MD, shares what he sees as the key upcoming highlights in thoracic oncology at the ASCO Annual Meeting.
Stephen V. Liu, MDLung Cancer | May 9, 2025
Dr. Liu discusses his experience as co-chair of the Texas Lung Cancer Conference and shares key highlights.
Stephen V. Liu, MDEGFR+ NSCLC | April 24, 2025
Dr. Liu discusses key data and updates in EGFR-positive NSCLC from the European Lung Cancer Congress.
Stephen V. Liu, MDImmunotherapy in NSCLC | April 7, 2025
Stephen V. Liu, MD, weighs in on the data from the preplanned interim analysis that was recently published in The Lancet.
Stephen V. Liu, MDELCC 2025 | March 24, 2025
Dr. Liu shares what he's looking forward to during the European Lung Cancer Congress, which will be held March 26-29.